Claudio Mapelli

This inventor holds 29 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Modified Relaxin Polypeptides. Top assignees: Bristol-Myers Squibb Compnay, Enichem S.p.a, Saladax Biomedical Inc.. Active years: 1995-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio Mapelli. Retrieved from https://idiyas.com/inventor/claudio-mapelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 9)

% Patents Active = 93.1

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 5.9

ph-index = 8

Forward Citations = 173(Granted Patents)

Location History:

Yardley, PA (US) (2015)
Lawrenceville, NJ (US) (2018)
Princeton, NJ (US) (1995 - 2020)
Plainsboro, NJ (US) (1996 - 2020)
Langhorne, PA (US) (2016 - 2020)
Linden, NJ (US) (2019 - 2024)

Company Filing History:

24 out of 3,742

Bristol-Myers Squibb Compnay

Saladax Biomedical Inc.

patents

4. 1 out of 834,513

Other

patents

Years Active: 1995-2024

Loading Chart...

Areas of Expertise:

Kidney Failure

Cardiovascular Disease

Immunomodulators

Modified Relaxin

Pharmacokinetic Enhancer

GLP-1 Receptor Modulators

Beta Secretase

Antimicrobial Peptides

Clinical Biomarkers

PD-1/PD-L1 Inhibitors

PAR4 Agonist Peptides

Fibrosis

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12097242 - Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides (2024-09-24),

2. 12097241 - Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides (2024-09-24),

3. 11952434 - Immunomodulators (2024-04-09),

4. 11364281 - Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof (2022-06-21),

5. 11358988 - Immunomodulators (2022-06-14),

6. 11185570 - Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides (2021-11-30),

7. 10823739 - Immunoassay standards and measurement of tau using intra-assay calibration standards (2020-11-03),

8. 10670612 - Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards (2020-06-02),

9. 10633419 - Immunomodulators (2020-04-28),

10. 10538555 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions (2020-01-21),

11. 10450347 - Immunomodulators (2019-10-22),

12. 10266578 - Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof (2019-04-23),

13. 9861680 - Immunomodulators (2018-01-09),

14. 9856292 - Immunomodulators (2018-01-02),

15. 9850283 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions (2017-12-26),

Sure, I can help with that! Here is the article about inventor Claudio Mapelli:

Title: Claudio Mapelli: Shaping the Future of Technology through Innovation

Introduction:

Claudio Mapelli, a passionate inventor based in Langhorne, PA, has made significant contributions to the field of biotechnology through his relentless pursuit of innovation and excellence. With 24 patents to his name, Mapelli's work continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents:

Mapelli's latest patents showcase his expertise in the biopharmaceutical industry. One of his recent inventions includes "Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof," which focuses on the treatment of cardiovascular conditions and fibrosis. Additionally, his work on "Immunomodulators" highlights the potential for ameliorating diseases such as cancer and infectious diseases through innovative compounds.

Career Highlights:

Having worked in esteemed companies like Bristol-Myers Squibb Company and Saladax Biomedical Inc., Mapelli has honed his skills and expertise in the biotech industry. His diverse experience has equipped him with the knowledge and vision to drive groundbreaking innovations in the field.

Collaborations:

Mapelli's collaborations with industry experts like Paul Michael Scola and Douglas James Riexinger have played a crucial role in his success as an inventor. Through teamwork and shared dedication to innovation, Mapelli and his colleagues have pushed boundaries and achieved remarkable advancements in biotechnology.

Conclusion:

In conclusion, Claudio Mapelli's unwavering commitment to innovation and his remarkable track record of patents underscore his status as a visionary in the field of biotechnology. His contributions continue to redefine the landscape of technology and inspire future generations of inventors to push the boundaries of what is possible.

I hope you find this article about Claudio Mapelli informative and inspiring. If you need more information or assistance, feel free to ask!

Profile summary based on public USPTO records.